Aiding COPD and CHF Ultrasound-guided Management Through ENhanced Point Of Care UltraSound

NCT05423652 · tracked via the Priya Life Science Canada tracker

Sponsor

Michelle Grinman

Phase

Not applicable

Started

2023-10-16

Last updated

2025-04-02

Condition(s) studied

COPDCHFPneumonia

Investigational drug(s) / intervention(s)

Lung point of care ultrasoundPRESUNA software

Lung point of care ultrasound: Point of care ultrasound of the lungs will be performed to enhance physical assessments as needed to make clinical decisions for patients with CHF, COPD and/or pneumonia. The majority of images will be acquired and uploaded to a web-based portal by community paramedics in patients' homes and interpreted remotely by hospital-based physicians on call for the home hospital.

PRESUNA software: PRESUNA is a new medical software that enables clinicians to summarize POCUS findings and document them on a platform that provides a visual summary of findings over time. PRESUNA also provides POCUS educators and learners to see the learners' progress over time in terms of the accuracy of their assessments when compared to POCUS experts providing longitudinal mentorship.

Study summary

Single-center, two-arm, parallel, randomized controlled trial comparing enhanced daily assessments for patients with COPD and/or CHF using point of care ultrasound with PRESUNA software (POCUS-PRESUNA) versus standard care provided by home-based acute care through a tertiary acute care medical teaching hospital. The objectives are to evaluate POCUS-PRESUNA on improving patient experience, provider experience, improve healthcare utilization/costs, and to test the feasibility of incorporating longitudinal POCUS assessments in home-based acute care via remotely acquired images by non-physicians.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Patient Inclusion Criteria: * 18 years of age or older * Has a provincial health care number * Functionally safe to receive HH care or have sufficient caregiving to support them at home * Stable enough to be cared for at home - stable vital signs and requiring no more than 2 visits per day * Able and willing to follow a management plan * Provides consent to receive care on HH * Diagnosis of CHF and/or COPD that requires HH care * No painful/broken ribs that could be affected by pressure applied when performing lung POCUS Patient Exclusion Criteria: * Not eligible for HH care * New unstable rib fractures * Prior history of allergy to ultrasound gel * Participant refusal to participate in research study Provider inclusion criteria * Attending clinician on the home hospital program within the next 3-6 months * Provides informed consent to participate in the study, including necessary training for the use of POCUS and/or PRESUNA Provider exclusion criteria * Not a home hospital clinician * Refuses to consent for the study / training.

Primary outcome measure(s)

Length of stay — From the date of admission to discharge from the index admission, assessed up to 1 year
Length of stay for index Home Hospital admission

Trial sites (1)

Facility	City	Region	Status
Rockyview General Hospital	Calgary	Canada

Other trials for the same condition

Evaluating the EAPOC-COPD System Starting soon

Passive Heat Therapy for People With COPD Recruiting

Bronchodilators and Lung Mechanics During Exercise in COPD Recruiting

PromotIng Optimal Treatment for Community-acquired PNeumonia in EmErgency Rooms Recruiting

Quebec Lung Cancer Screening PLUS Trial Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05423652 on ClinicalTrials.gov ↗ ← All trials in Canada